Citadel Advisors’s Defiance Daily Target 2x Long RCAT ETF RCAX Stock Holding History

Citadel Advisors’s Portfolio RCAX Stock Details RCAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,608	Closed	-$282K	–	15427
2026 Q1	$282K	Buy	+20,608	New	+$370K	﹤0.01%	10601

Other funds holding RCAX

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Citadel Advisors's RCAX Position: Q2 2026 in Review

Citadel Advisors sold out of Defiance Daily Target 2x Long RCAT ETF (RCAX) in Q2 2026, closing a stake of 20,608 shares — an estimated $282K sold.

Citadel Advisors first reported a position in RCAX in Q1 2026 and held it in 1 quarter. The position peaked at $282K in Q1 2026. 3 funds tracked by Wall St. Rank hold RCAX as of Q2 2026.

Citadel Advisors reported no remaining Defiance Daily Target 2x Long RCAT ETF position as of Q2 2026 after selling out during the quarter.
Citadel Advisors sold 20,608 Defiance Daily Target 2x Long RCAT ETF shares in Q2 2026, an estimated $282K.
Citadel Advisors first reported a position in Defiance Daily Target 2x Long RCAT ETF in Q1 2026 and held it in 1 quarter.
Citadel Advisors's Defiance Daily Target 2x Long RCAT ETF position peaked at $282K in Q1 2026.
3 funds tracked by Wall St. Rank held Defiance Daily Target 2x Long RCAT ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.